Recent Security Class Actions
Zynerba Pharmaceuticals Inc. Common Stock (NASDAQ: ZYNE)
Company Name:Zynerba Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: ZYNE
Class Period Start:03/11/2019
Class Period End (inclusive):09/17/2019
Filing Deadline:12/22/2019
According to the Complaint, Zynerba Pharmaceuticals, Inc. was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba operates as a clinical stage specialty pharmaceutical company. The Company focuses on developing pharmaceutically-produced transdermal CBD therapies for rare and near-rare neuropsychiatric disorders.
